HAYWARD, Calif.--(BUSINESS WIRE)--
Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that the
Company will release its first quarter 2013 financial results on
Wednesday, May 1, 2013, after the close of the U.S. financial markets.
The Company will host a conference call and live webcast with the
investment community at 4:30 p.m., Eastern Time on May 1, 2013.
The financial results and live webcast will be accessible through the
Investor Relations section of the Company's Web site, www.impaxlabs.com.
To access the call through a conference line, dial (877) 356-3814 (in
the U.S.) and (706) 758-0033 (international callers). The conference ID
is 32064217.
A replay of the conference call will be available for seven days shortly
after the call. To access the replay, dial (855) 859-2056 (in the U.S.)
and (404) 537-3406 (international callers). The access code for the
replay is 32064217.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (Impax) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of central nervous
system disorder branded products. Impax markets its generic products
through its Global Pharmaceuticals division and markets its branded
products through the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax develops marketing partnerships to
fully leverage its technology platform and pursues partnership
opportunities that offer alternative dosage form technologies, such as
injectables, nasal sprays, inhalers, patches, creams and ointments.
Impax Laboratories is headquartered in Hayward, California, and has a
full range of capabilities in its Hayward, Philadelphia, Pennsylvania
and Taiwan facilities. For more information, please visit the Company's
Web site at: www.impaxlabs.com.
Source: Impax Laboratories, Inc.